Management of clinical issues detected through remote monitoring of cardiac implantable electronic devices: Recommendations from a Delphi Consensus process

作者：B. Sheahen, Edel O’Hagan, Kenneth Cho, Gopal Sivagangabalan, Pierre Qian, Aravinda Thiagalingam, Samual Turnbull, James Leitch, Miriam Norman, Graham S. Hillis, Andien Munawar, R. Gluer, H. Dimitri, Irene Stevenson, Jo-Dee Lattimore, Saurabh Kumar, W. Chik, Hui‐Chen Han, Ihab El-Sokkar, Haris M. Haqqani, Gareth Wynn, Jens Kilian, Justin A. Mariani, Leonard Kritharides, Matthew Tung, Prashanthan Sanders, Rohan Jayasinghe, Sachin Nayyar, L. Davis, Stephen M. Brown, Zoe Rock, Liliana Laranjo, Tim Shaw, Simone Marschner, Clara K Chow · 发表于：Heart Rhythm · 年份：2025 · DOI：10.1016/j.hrthm.2025.07.036 · 被引用次数：5 · 研究领域：Cardiac pacing and defibrillation studies、Cardiac Arrhythmias and Treatments、Atrial Fibrillation Management and Outcomes

Remote monitoring (RM) of cardiac implantable electronic devices (CIED) has increased substantially in recent years in line with an expanding evidence base as well as the normalization of telehealth and virtual care for health services.1 Clinical trials have demonstrated the benefits of RM in improving clinical outcomes2–5 and also shown RM to be highly acceptable to patients and staff.6,7 Several cardiac organizations, including the Heart Rhythm Society,1 European Heart Rhythm Association,1 and the Cardiac Society of Australia and New Zealand (CSANZ)8,9 recommend offering all patients RM where feasible.